Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AGIO |
---|---|---|
09:32 ET | 5343 | 33.15 |
09:34 ET | 300 | 33.63 |
09:36 ET | 2800 | 33.5 |
09:38 ET | 600 | 33.5 |
09:39 ET | 100 | 33.46 |
09:41 ET | 100 | 33.46 |
09:43 ET | 1200 | 33.5 |
09:45 ET | 200 | 33.29 |
09:48 ET | 100 | 33.3 |
09:50 ET | 500 | 33.335 |
09:52 ET | 400 | 33.27 |
09:56 ET | 264 | 33.25 |
09:59 ET | 300 | 33.18 |
10:01 ET | 200 | 33.19 |
10:03 ET | 300 | 33.14 |
10:06 ET | 1733 | 33.19 |
10:08 ET | 600 | 33.37 |
10:10 ET | 500 | 33.215 |
10:12 ET | 100 | 33.265 |
10:14 ET | 500 | 33.22 |
10:15 ET | 100 | 33.19 |
10:17 ET | 100 | 33.16 |
10:19 ET | 400 | 33.215 |
10:21 ET | 900 | 33.215 |
10:24 ET | 704 | 33.195 |
10:26 ET | 300 | 33.15 |
10:28 ET | 500 | 33.185 |
10:30 ET | 700 | 33.17 |
10:32 ET | 1500 | 33.18 |
10:33 ET | 1500 | 33.27 |
10:35 ET | 200 | 33.25 |
10:37 ET | 200 | 33.2 |
10:39 ET | 659 | 33.18 |
10:42 ET | 100 | 33.17 |
10:44 ET | 840 | 33.1 |
10:46 ET | 300 | 33.085 |
10:48 ET | 300 | 33 |
10:51 ET | 100 | 32.97 |
10:53 ET | 200 | 32.92 |
10:55 ET | 1514 | 33.025 |
11:00 ET | 916 | 33.01 |
11:02 ET | 860 | 33.045 |
11:04 ET | 100 | 33.1 |
11:08 ET | 900 | 33.0575 |
11:09 ET | 347 | 32.985 |
11:11 ET | 100 | 32.93 |
11:13 ET | 100 | 32.83 |
11:15 ET | 1320 | 32.85 |
11:18 ET | 100 | 32.88 |
11:20 ET | 600 | 32.86 |
11:22 ET | 100 | 32.885 |
11:26 ET | 1599 | 32.95 |
11:27 ET | 600 | 33.02 |
11:29 ET | 1000 | 33 |
11:31 ET | 2100 | 32.98 |
11:33 ET | 600 | 32.95 |
11:36 ET | 201 | 32.95 |
11:40 ET | 2961 | 33.08 |
11:42 ET | 1104 | 33.18 |
11:44 ET | 600 | 33.25 |
11:47 ET | 200 | 33.28 |
11:49 ET | 1837 | 33.24 |
11:51 ET | 1000 | 33.3 |
11:54 ET | 100 | 33.3 |
11:56 ET | 200 | 33.29 |
11:58 ET | 300 | 33.29 |
12:02 ET | 100 | 33.27 |
12:03 ET | 1035 | 33.26 |
12:05 ET | 467 | 33.28 |
12:09 ET | 200 | 33.26 |
12:12 ET | 2671 | 33.31 |
12:14 ET | 100 | 33.31 |
12:16 ET | 1082 | 33.31 |
12:18 ET | 100 | 33.335 |
12:20 ET | 116 | 33.36 |
12:21 ET | 100 | 33.33 |
12:23 ET | 100 | 33.33 |
12:25 ET | 700 | 33.3 |
12:27 ET | 100 | 33.235 |
12:30 ET | 1466 | 33.29 |
12:32 ET | 100 | 33.285 |
12:34 ET | 800 | 33.315 |
12:36 ET | 500 | 33.35 |
12:38 ET | 100 | 33.35 |
12:39 ET | 100 | 33.38 |
12:41 ET | 200 | 33.35 |
12:43 ET | 100 | 33.31 |
12:45 ET | 2017 | 33.375 |
12:48 ET | 200 | 33.39 |
12:50 ET | 100 | 33.39 |
12:52 ET | 1600 | 33.5 |
12:54 ET | 306 | 33.42 |
12:56 ET | 100 | 33.41 |
12:57 ET | 1200 | 33.465 |
01:01 ET | 963 | 33.405 |
01:03 ET | 1400 | 33.4 |
01:06 ET | 100 | 33.4 |
01:08 ET | 900 | 33.4 |
01:10 ET | 2227 | 33.33 |
01:12 ET | 1122 | 33.34 |
01:14 ET | 900 | 33.35 |
01:15 ET | 300 | 33.35 |
01:17 ET | 300 | 33.4 |
01:19 ET | 100 | 33.39 |
01:21 ET | 200 | 33.39 |
01:24 ET | 600 | 33.39 |
01:26 ET | 502 | 33.35 |
01:28 ET | 400 | 33.37 |
01:30 ET | 100 | 33.4 |
01:32 ET | 500 | 33.4 |
01:33 ET | 2504 | 33.42 |
01:37 ET | 100 | 33.46 |
01:42 ET | 100 | 33.42 |
01:44 ET | 1524 | 33.4 |
01:46 ET | 2485 | 33.39 |
01:48 ET | 900 | 33.375 |
01:50 ET | 1374 | 33.375 |
01:51 ET | 2700 | 33.39 |
01:53 ET | 3801 | 33.33 |
01:55 ET | 100 | 33.38 |
02:00 ET | 371 | 33.34 |
02:02 ET | 410 | 33.31 |
02:04 ET | 100 | 33.35 |
02:06 ET | 300 | 33.34 |
02:08 ET | 400 | 33.39 |
02:11 ET | 400 | 33.38 |
02:13 ET | 500 | 33.38 |
02:18 ET | 400 | 33.44 |
02:20 ET | 300 | 33.485 |
02:22 ET | 2193 | 33.495 |
02:24 ET | 1400 | 33.46 |
02:27 ET | 300 | 33.4 |
02:29 ET | 3665 | 33.35 |
02:31 ET | 808 | 33.36 |
02:36 ET | 402 | 33.36 |
02:38 ET | 500 | 33.37 |
02:40 ET | 2300 | 33.4 |
02:42 ET | 1820 | 33.4 |
02:44 ET | 1300 | 33.4 |
02:45 ET | 700 | 33.4 |
02:47 ET | 1408 | 33.385 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Agios Pharmaceuticals Inc | 1.9B | -5.3x | --- |
NewAmsterdam Pharma Company NV | 1.9B | -7.7x | --- |
CG Oncology Inc | 1.9B | -23.8x | --- |
Syndax Pharmaceuticals Inc | 1.8B | -6.5x | --- |
Fusion Pharmaceuticals Inc | 1.8B | -15.1x | --- |
Inhibrx Inc | 1.8B | -6.4x | --- |
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of alpha- and beta- thalassemia and sickle cell disease (SCD) in ongoing clinical trials. The Company is also developing AG-946, a clinical-stage oral activator of PKR enzymes for the treatment of hemolytic anemias and other indications, including SCD.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.9B |
---|---|
Revenue (TTM) | $29.4M |
Shares Outstanding | 56.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.75 |
EPS | $-6.31 |
Book Value | $14.50 |
P/E Ratio | -5.3x |
Price/Sales (TTM) | 63.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,336.42% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.